Anette Schrag

43.5k total citations · 8 hit papers
308 papers, 22.4k citations indexed

About

Anette Schrag is a scholar working on Neurology, Cognitive Neuroscience and Epidemiology. According to data from OpenAlex, Anette Schrag has authored 308 papers receiving a total of 22.4k indexed citations (citations by other indexed papers that have themselves been cited), including 247 papers in Neurology, 43 papers in Cognitive Neuroscience and 41 papers in Epidemiology. Recurrent topics in Anette Schrag's work include Parkinson's Disease Mechanisms and Treatments (228 papers), Neurological disorders and treatments (123 papers) and Botulinum Toxin and Related Neurological Disorders (46 papers). Anette Schrag is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (228 papers), Neurological disorders and treatments (123 papers) and Botulinum Toxin and Related Neurological Disorders (46 papers). Anette Schrag collaborates with scholars based in United Kingdom, United States and Germany. Anette Schrag's co-authors include Niall Quinn, Andrew J. Lees, Werner Poewe, Anthony E. Lang, Klaus Seppi, Jens Volkmann, Caroline M. Tanner, Glenda M. Halliday, Patrik Brundin and Alastair J. Noyce and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Anette Schrag

295 papers receiving 21.8k citations

Hit Papers

Parkinson disease 2000 2026 2008 2017 2017 2000 2007 2012 2014 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Parkinson disease
    2017 3.3k citations Klaus Seppi, Anette Schrag et al. profile →
  2. What contributes to quality of life in patients with Parkinson's disease?
    2000 1.0k citations Anette Schrag Journal of Neurology Neurosurgery & Psychiatry profile →
  3. Depression rating scales in Parkinson's disease: Critique and recommendations
    2007 521 citations Anette Schrag, Richard G. Brown et al. Movement Disorders profile →
  4. Meta‐analysis of early nonmotor features and risk factors for Parkinson disease
    2012 515 citations Alastair J. Noyce, Gavin Giovannoni et al. Annals of Neurology profile →
  5. Prediagnostic presentations of Parkinson's disease in primary care: a case-control study
    2014 477 citations Anette Schrag, Alastair J. Noyce et al. profile →
  6. Visual dysfunction in Parkinson’s disease
    2016 308 citations Rimona S. Weil, Anette Schrag et al. Brain profile →
  7. Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study
    2016 304 citations Anette Schrag, Daniel Weintraub et al. profile →
  8. European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies
    2022 100 citations Günther Deuschl, Angelo Antonini et al. Movement Disorders profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anette Schrag United Kingdom 71 16.6k 4.5k 3.3k 3.1k 2.4k 308 22.4k
Angelo Antonini Italy 78 15.8k 1.0× 5.4k 1.2× 2.0k 0.6× 3.5k 1.1× 1.8k 0.7× 529 21.0k
Paolo Barone Italy 71 12.3k 0.7× 4.2k 0.9× 2.7k 0.8× 3.4k 1.1× 1.5k 0.6× 418 17.6k
Caroline M. Tanner United States 73 16.5k 1.0× 5.7k 1.3× 2.0k 0.6× 2.4k 0.8× 2.9k 1.2× 254 24.0k
К. Ray Chaudhuri United Kingdom 82 24.6k 1.5× 5.2k 1.2× 3.0k 0.9× 5.3k 1.7× 2.9k 1.2× 694 33.0k
Michael S. Okun United States 75 20.6k 1.2× 8.8k 2.0× 3.1k 0.9× 4.7k 1.5× 3.7k 1.5× 719 29.8k
Charles H. Adler United States 73 19.5k 1.2× 5.3k 1.2× 3.4k 1.0× 4.3k 1.4× 2.9k 1.2× 313 25.7k
Olivier Rascol France 86 20.8k 1.3× 7.7k 1.7× 2.7k 0.8× 4.7k 1.5× 3.0k 1.2× 434 27.5k
Glenn T. Stebbins United States 72 12.0k 0.7× 3.0k 0.7× 4.0k 1.2× 5.0k 1.6× 1.3k 0.6× 271 18.1k
J. Eric Ahlskog United States 80 13.3k 0.8× 5.2k 1.2× 2.1k 0.7× 2.4k 0.8× 2.2k 0.9× 279 19.9k
Wolfgang H. Oertel Germany 71 15.9k 1.0× 6.0k 1.3× 2.2k 0.7× 3.6k 1.1× 3.1k 1.3× 292 23.4k

Countries citing papers authored by Anette Schrag

Since Specialization
Citations

This map shows the geographic impact of Anette Schrag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anette Schrag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anette Schrag more than expected).

Fields of papers citing papers by Anette Schrag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anette Schrag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anette Schrag. The network helps show where Anette Schrag may publish in the future.

Co-authorship network of co-authors of Anette Schrag

This figure shows the co-authorship network connecting the top 25 collaborators of Anette Schrag. A scholar is included among the top collaborators of Anette Schrag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anette Schrag. Anette Schrag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Subramanian, Indu, Lucia Ricciardi, Anette Schrag, et al.. (2025). A Holistic Wellness Prescription for Parkinson's Disease: Evidence‐Based Perspectives and Unmet Needs. Movement Disorders Clinical Practice. 13(3). 631–646.
2.
Chaudhuri, К. Ray, Alexandra Rizos, Carmen Rodríguez‐Blázquez, et al.. (2025). Conversion between NMSS and MDS‐NMS in Parkinson's Disease. Movement Disorders. 40(5). 813–820. 1 indexed citations
3.
Schrag, Anette, et al.. (2024). Quick MSA-QoL: A validated, abbreviated health-related quality of life questionnaire for use in Multiple System Atrophy. Parkinsonism & Related Disorders. 128. 107143–107143. 1 indexed citations
4.
Subramanian, Indu, et al.. (2023). Delivering the diagnosis of Parkinson's disease- setting the stage with hope and compassion. Parkinsonism & Related Disorders. 118. 105926–105926. 12 indexed citations
5.
Schrag, Anette, et al.. (2023). Development of anxiety in early Parkinson's disease: A clinical and biomarker study. European Journal of Neurology. 30(9). 2661–2668. 5 indexed citations
6.
Deuschl, Günther, Angelo Antonini, João Costa, et al.. (2022). European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies. Movement Disorders. 37(7). 1360–1374. 100 indexed citations breakdown →
7.
Oliveira, Beatriz Guitton Renaud Baptista de, Christopher G. Goetz, Donald E. Morisky, et al.. (2022). Rating Scales for Medication Adherence in Parkinson's Disease: A Systematic Review for Critique and Recommendations. Movement Disorders Clinical Practice. 10(2). 175–189. 2 indexed citations
8.
Jensen, Melanie P., Benjamin M. Jacobs, Ruth Dobson, et al.. (2021). Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease. Annals of Neurology. 89(4). 803–812. 56 indexed citations
9.
Buchanan, Sarah M., Marcus Richards, Jonathan M. Schott, & Anette Schrag. (2021). Mild Parkinsonian Signs: A Systematic Review of Clinical, Imaging, and Pathological Associations. Movement Disorders. 36(11). 2481–2493. 23 indexed citations
10.
Oxtoby, Neil P., Louise‐Ann Leyland, Leon Aksman, et al.. (2021). Sequence of clinical and neurodegeneration events in Parkinson’s disease progression. Brain. 144(3). 975–988. 60 indexed citations
11.
Walker, Zuzana, Jan Booij, Sachit Shah, et al.. (2020). Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson’s disease: a cross-sectional study. Journal of Neurology Neurosurgery & Psychiatry. 92(2). 158–164. 43 indexed citations
12.
Bremner, F D, et al.. (2019). Visual tests predict dementia risk in Parkinson's disease. UCL Discovery (University College London). 4 indexed citations
13.
Evans, Andrew, David Okai, Daniel Weintraub, et al.. (2019). Scales to assess impulsive and compulsive behaviors in Parkinson's disease: Critique and recommendations. Movement Disorders. 34(6). 791–798. 51 indexed citations
14.
Pontone, Gregory M., N. Dissanayaka, Liana G. Apostolova, et al.. (2019). Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease. npj Parkinson s Disease. 5(1). 30–30. 29 indexed citations
15.
Schrag, Anette & Raquel N. Taddei. (2017). Depression and Anxiety in Parkinson's Disease. International review of neurobiology. 133. 623–655. 114 indexed citations
16.
Katzenschlager, Regina, Jenny Head, Anette Schrag, et al.. (2008). Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD. Neurology. 71(7). 474–480. 181 indexed citations
17.
Edwards, Mark J., Davide Martino, Maria Bozi, et al.. (2004). Anti-basal ganglia antibodies in patients with atypical dystonia and tics - A prospective study. UCL Discovery (University College London). 1 indexed citations
18.
Schrag, Anette, et al.. (2004). Factors contributing to caregiver burden and carer quality of life in Parkinson's disease. UCL Discovery (University College London). 1 indexed citations
19.
Schrag, Anette & Niall Quinn. (1999). Disorders of the Basal Ganglia and Their Modern Management. Journal of the Royal College of Physicians of London. 33(4). 323–327. 3 indexed citations
20.
Schrag, Anette, et al.. (1999). Benign hereditary chorea: Entity or syndrome?. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelo Antonini Breakdown of academic impact, for papers by Paolo Barone Breakdown of academic impact, for papers by Caroline M. Tanner Breakdown of academic impact, for papers by К. Ray Chaudhuri Breakdown of academic impact, for papers by Michael S. Okun Breakdown of academic impact, for papers by Charles H. Adler Breakdown of academic impact, for papers by Olivier Rascol Breakdown of academic impact, for papers by Glenn T. Stebbins Breakdown of academic impact, for papers by J. Eric Ahlskog Breakdown of academic impact, for papers by Wolfgang H. Oertel
Rankless by CCL
2026